Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 3/20 | 0.61 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.44 |
| ▸ | THRB | P10828 | 1/20 | 0.42 |
| ▸ | POLB | P06746 | 1/20 | 0.32 |
| ▸ | APEX1 | P27695 | 1/20 | 0.32 |
| ▸ | HTT | P42858 | 1/20 | 0.32 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.32 |
| ▸ | MGAM | O43451 | 1/20 | 0.30 |
| ▸ | GAA | P10253 | 1/20 | 0.30 |
| ▸ | SI | P14410 | 1/20 | 0.30 |
| ▸ | MGAM2 | Q2M2H8 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27398964 | 0.83 | TSHR (0.61) | TSHRALDH1A1THRBPOLBAPEX1 | |
| SCHEMBL4399857 | 0.82 | TSHR (0.64) | TSHRALDH1A1THRBPOLBAPEX1 | |
| SCHEMBL28874573 | 0.82 | TSHR (0.59) | TSHRALDH1A1THRBPOLBAPEX1 | |
| SCHEMBL12803643 | 0.80 | TSHR (0.62) | TSHRALDH1A1THRBPOLBAPEX1 | |
| SCHEMBL2504502 | 0.80 | TSHR (0.57) | TSHRALDH1A1THRBPOLBAPEX1 | |
| SCHEMBL2003087 | 0.80 | TSHR (0.57) | TSHRALDH1A1THRBPOLBAPEX1 | |
| SCHEMBL26031177 | 0.79 | TSHR (0.55) | TSHRALDH1A1THRB | |
| SCHEMBL2517022 | 0.79 | TSHR (0.55) | TSHRALDH1A1THRBMGAMGAA | |
| SCHEMBL147268 | 0.78 | TSHR (0.71) | TSHRALDH1A1THRBPOLBAPEX1 | |
| SCHEMBL8886282 | 0.77 | TSHR (0.53) | TSHRALDH1A1THRB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 79 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3004033-B1 | METHOD FOR PURIFICATION OF 18F-LABELED CHOLINE ANALOGUES | TRASIS S A (BE) | 2019-05-08 | — | — | EP | claimed |
| US-9839702-B2 | Method for purification of 18F-labeled choline analogues | TRASIS S.A. (BE) | 2017-12-12 | — | — | US | claimed |
| EP-2148836-B1 | METHOD FOR THE PREPARATION OF REACTIVE [18]F FLUORIDE | TRASIS S A (BE) | 2017-10-25 | — | — | EP | claimed |
| US-20160129139-A1 | Method for Purification of 18F-Labeled Choline Analogues | TRASIS S.A. (BE) | 2016-05-12 | — | — | US | claimed |
| EP-3004033-A1 | METHOD FOR PURIFICATION OF 18F-LABELED CHOLINE ANALOGUES | Trasis S.A. (BE) | 2016-04-13 | — | — | EP | claimed |
| US-9284188-B2 | Cytosolic delivery of materials with endosome-disrupting colloids | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2016-03-15 | — | — | US | claimed |
| EP-2845608-A1 | Method for purification of 18F-labeled choline analogues | Trasis S.A. (BE) | 2015-03-11 | — | — | EP | claimed |
| WO-2014195249-A1 | METHOD FOR PURIFICATION OF 18F-LABELED CHOLINE ANALOGUES | TRASIS S.A. (BE) | 2014-12-11 | — | — | WO | claimed |
| US-8641903-B2 | Method for the preparation of reactive [18] F fluoride | TRASIS S.A. (BE) | 2014-02-04 | — | — | US | claimed |
| US-20120058505-A1 | Cytosolic Delivery of Materials with Endosome-Disrupting Colloids | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2012-03-08 | — | — | US | claimed |
| US-20100243972-A1 | METHOD FOR THE PREPARATION OF REACTIVE [18] F FLUORIDE | TRASIS S.A. (BE) | 2010-09-30 | — | — | US | claimed |
| WO-2026102309-A1 | SELECTIVE RADIOTRACERS AND METHODS OF USE | LUTROO IMAGING, LLC (US) | 2026-05-15 | — | — | WO | disclosed |
| EP-4121121-A1 | RADIONUCLIDE TRACERS OF 1-AMINO-3,4-DIFLUOROCYCLOPENTANE-1-CARBOXYLIC ACID, DERIVATIVES, AND USES THEREOF | Emory University (US) | 2023-01-25 | — | — | EP | disclosed |
| CN-109791353-A | Photosensitive polymer combination and photoresist printing plate precursor comprising it | 东丽株式会社 | 2019-05-21 | — | — | CN | disclosed |
| EP-3004033-B1 | METHOD FOR PURIFICATION OF 18F-LABELED CHOLINE ANALOGUES | TRASIS S A (BE) | 2019-05-08 | — | — | EP | disclosed |
| EP-1572154-A2 | MEDICAL DEVICES EMPLOYING NOVEL POLYMERS | Polymerix Corporation (US) | 2005-09-14 | — | — | EP | disclosed |
| WO-2005042600-A2 | HIGH MOLECULAR WEIGHT POLYMERS, DEVICES AND METHOD FOR MAKING AND USING SAME | POLYMERIX CORPORATION (US) | 2005-05-12 | — | — | WO | disclosed |
| WO-2005039489-A2 | COMPOSITIONS AND METHODS FOR THE INHIBITION OF BONE GROWTH AND RESORPTION | POLYMERIX CORPORATION (US) | 2005-05-06 | — | — | WO | disclosed |
| US-20050048121-A1 | Sustained release; acylation, dehydration a diacid in presence of nonaqueous solvent | POLYMERIX CORPORATION (US) | 2005-03-03 | — | — | US | disclosed |
| WO-2004045549-A2 | MEDICAL DEVICES EMPLOYING NOVEL POLYMERS | POLYMERIX CORPORATION (US) | 2004-06-03 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050048121-A1 | Sustained release; acylation, dehydration a diacid in presence of nonaqueous solvent | ACMSD, CCND1, SMCHD1 | TSHR 4219/4885ALDH1A1 1272/4885THRB 3598/4885 |
| US-20160129139-A1 | Method for Purification of 18F-Labeled Choline Analogues | SLC5A7, CHAT, CHKA | TSHR 1161/4885ALDH1A1 2903/4885THRB 2030/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.